Page last updated: 2024-09-03

sch 23982 and Meningioma

sch 23982 has been researched along with Meningioma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fahlbusch, R; Nomikos, P; Schrell, UM1
Adams, EF; Fahlbusch, R; Nomikos, P; Reif, M; Schrell, UM1

Other Studies

2 other study(ies) available for sch 23982 and Meningioma

ArticleYear
Presence of dopamine D1 receptors and absence of dopamine D2 receptors in human cerebral meningioma tissue.
    Journal of neurosurgery, 1992, Volume: 77, Issue:2

    Topics: Adult; Aged; Benzazepines; Female; Guanylyl Imidodiphosphate; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2

1992
Growth of cultured human cerebral meningiomas is inhibited by dopaminergic agents. Presence of high affinity dopamine-D1 receptors.
    The Journal of clinical endocrinology and metabolism, 1990, Volume: 71, Issue:6

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Apomorphine; Benzazepines; Binding, Competitive; Bromocriptine; Butaclamol; Cell Division; Dopamine; Dopamine Agents; Humans; Meningioma; Receptors, Dopamine; Receptors, Dopamine D1; Tumor Cells, Cultured

1990